Your browser doesn't support javascript.
loading
Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells.
Posch, Christian; Sanlorenzo, Martina; Vujic, Igor; Oses-Prieto, Juan A; Cholewa, Brian D; Kim, Sarasa T; Ma, Jeffrey; Lai, Kevin; Zekhtser, Mitchell; Esteve-Puig, Rosaura; Green, Gary; Chand, Shreya; Burlingame, Alma L; Panzer-Grümayer, Renate; Rappersberger, Klemens; Ortiz-Urda, Susana.
Affiliation
  • Posch C; Department of Dermatology, Mt. Zion Cancer Research Center, University of California San Francisco, San Francisco, California, USA; Department of Dermatology, The Rudolfstiftung Hospital, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria; Leukemia Biology Group, Children's Cance
  • Sanlorenzo M; Department of Dermatology, Mt. Zion Cancer Research Center, University of California San Francisco, San Francisco, California, USA; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Vujic I; Department of Dermatology, Mt. Zion Cancer Research Center, University of California San Francisco, San Francisco, California, USA; Department of Dermatology, The Rudolfstiftung Hospital, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria; School of Medicine, Sigmund Freud Univer
  • Oses-Prieto JA; Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Cholewa BD; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kim ST; Department of Dermatology, Mt. Zion Cancer Research Center, University of California San Francisco, San Francisco, California, USA.
  • Ma J; Department of Dermatology, Mt. Zion Cancer Research Center, University of California San Francisco, San Francisco, California, USA.
  • Lai K; Department of Dermatology, Mt. Zion Cancer Research Center, University of California San Francisco, San Francisco, California, USA.
  • Zekhtser M; Department of Dermatology, Mt. Zion Cancer Research Center, University of California San Francisco, San Francisco, California, USA.
  • Esteve-Puig R; Department of Dermatology, Mt. Zion Cancer Research Center, University of California San Francisco, San Francisco, California, USA.
  • Green G; Department of Dermatology, Mt. Zion Cancer Research Center, University of California San Francisco, San Francisco, California, USA.
  • Chand S; Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Burlingame AL; Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Panzer-Grümayer R; Leukemia Biology Group, Children's Cancer Research Institute, Vienna, Austria.
  • Rappersberger K; Department of Dermatology, The Rudolfstiftung Hospital, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria.
  • Ortiz-Urda S; Department of Dermatology, Mt. Zion Cancer Research Center, University of California San Francisco, San Francisco, California, USA.
J Invest Dermatol ; 136(10): 2041-2048, 2016 10.
Article in En | MEDLINE | ID: mdl-27251789
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Proteomics / GTP Phosphohydrolases / Melanocytes / Melanoma / Membrane Proteins Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Invest Dermatol Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Proteomics / GTP Phosphohydrolases / Melanocytes / Melanoma / Membrane Proteins Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Invest Dermatol Year: 2016 Type: Article